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The third and fourth cases of maternal cystic fibrosis diag­
nosed during pregnancy are presented. Quantitative pilocar­
pine iontophoresis (sweat chlorides) must be performed to 
establish the diagnosis. Other important findings include 
recurrent or persistent respiratory symptoms, chest x-ray 
abnormalities, abnormal pulmonary function studies, and 
abnormal arterial blood gases. Gastrointestinal tract dys­
function and a positive family history for respiratory disease 
also suggest the diagnosis. Pregnant patients with cystic 
fibrosis require careful and frequent cardiopulmonary and 
gastrointestinal surveillance. A higher incidence of prema­
ture labor is noted and all patients are best managed in 
tertiary referral centers. Patients should also be monitored 
carefully during the puerperium because maternal pulmo­
nary decompensation may occur during this time. (Obstet 
Gynecol 61-.2S, 1983)
Because of improved diagnosis and treatm ent, an 
increasing num ber of children suffering from cystic 
fibrosis are surviving to adulthood . 1 More pregnancies 
complicated by maternal cystic fibrosis are also being 
reported ,2-11 although the initial diagnosis of cystic 
fibrosis has only rarely been made in pregnancy .2,4 The 
authors wish to report the third and fourth cases of 
maternal cystic fibrosis diagnosed during pregnancy.
The first previously reported case, reported in 1960, 
was in a 20-year-old primigravida with a history of 
persistent cough and recurrent pneum onia since age 
12, previously diagnosed as bronchiectasis.2 Her brother 
was being treated for cystic fibrosis. A sweat chloride 
study during pregnancy showed an elevated chloride 
value of 79.8 mEq/liter (normal, less than  60 mEq/liter). 
The patient was treated for the rem ainder of her 
pregnancy with nutritional supplem ents and antibiot­
ics. She delivered spontaneously at 34 weeks' gestation 
but died 1 month post partum  of respiratory failure.
The second wom an was seen at a regional care
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center at 31 w eeks' gestation w ith an exacerbation of 
life-long unexplained respiratory sym ptom s .4 Results 
of sweat chloride testing locally had been normal. 
Results of repeat testing were abnormal, and the 
diagnosis of cystic fibrosis was m ade. The rem ainder of 
labor, delivery, and postpartum  course were unre­
markable.
The authors present 2 additional cases, discuss the 
criteria for diagnosis of cystic fibrosis in adults, and 




SW, a 24-year-old primigravid white woman, was first seen at 
University of Iowa Hospitals on January 23, 1978, at 22 
weeks' gestation. She was referred for evaluation of produc­
tive cough and shortness of breath that began in the first 
trimester. She had been admitted to her local hospital for 
presumed asthma attacks, but did not respond to antibiotics 
or bronchodilators. She had no fever, chills, or steatorrhea, 
but had lost 2.25 kg over the preceding month.
Before the pregnancy she had never been hospitalized and 
had taken no medications. She had had nonspecific respira­
tory allergies since childhood. Her brother died at age 17 of 
cystic fibrosis; she had never undergone a sweat chloride 
test.
On admission she was noted to be a thin woman in 
moderate respiratory distress. Examination revealed poor 
chest wall expansion and use of accessory muscles, diffuse 
inspiratory rhonchi, diffuse expiratory wheezing, and hyper­
resonance with dullness to percussion. Uterine size was 
consistent with a 22-week gestation. Laboratory studies in­
cluded forced vital capacity in 1 second (FEV,), 200 to 250 ml 
(normal, 2.7 liters); and vital capacity, 500 ml (normal, 3120 
ml). Arterial blood gases on 8 liters of oxygen were Po2, 64 
torr; Pco2, 40 torr; and pH, 7.39. Sputum cultures grew 
Pseudomonas aeruginosa. The chest x-ray showed bronchial 
wall thickening and dilatation, particularly in the basal seg­
ments. On the basis of these findings, sweat chloride testing
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was performed by the quantitative pilocarpine iontophoresis 
method with 65 mEq/liter chloride in a volume of 117.3 mg 
sweat initially and 57 mEq/liter in a volume of 127.3 mg sweat 
on a repeat study.
The patient was treated with aminophyllin, gentamicin, 
carbenicillin, oxygen, intravenous hydration, and vigorous 
pulmonary toilet. She did well for 10 days until intermittent 
lower abdominal pain developed. Premature labor was sus­
pected, but the cervix was undilated and no contractions 
were palpable. Serum amylase was 1320 U/dl (normal, 45 to 
200 U/dl), prompting the diagnosis of pancreatitis. The pa­
tient was treated with peripheral venous nutrition and cime- 
tidine. She gradually improved and was sent home 4 weeks 
later on a regimen of ampicillin, general diet, and supple­
mental oxygen.
The patient was readmitted at 33 weeks' gestation with 
increasing respiratory symptoms and deterioration of pulmo­
nary function. Sputum cultures again grew P aeruginosa. The 
patient was treated with intravenous tobramycin, carbenicil­
lin, and aminophyllin. The membranes ruptured spontane­
ously 5 days after admission. After an unremarkable sponta­
neous labor an 1800-g female infant was delivered by low 
forceps with Apgar scores of 8 and 9 at 1 and 5 minutes, 
respectively. The infant did well and was discharged in good 
condition. Sweat chloride studies were performed on the 
infant at 2 months of age, with chloride values of 5.9 and 6.1 
mEq/liter in 141.6 and 93.9 mg sweat, respectively. The child 
has followed normal developmental milestones to 43 months 
of age.
The patient remained stable post partum and resumed oral 
diet. Ampicillin therapy was begun 2 days after delivery and 
the other antibiotics were discontinued. She gradually im­
proved, but on the eleventh postpartum day she had acute 
pulmonary decompensation. Vital capacity, maximum mid- 
expiratory flow rate, and FEV, all decreased dramatically and 
C02 retention requiring mechanical ventilation developed. 
Intravenous antibiotic therapy was resumed. The condition 
was stabilized but the patient could not be weaned from the 
ventilator. After 12 days a tracheostomy was performed in an 
attempt to improve control of secretions. Despite these 
measures, there was a progressive decline in pulmonary 
compliance and the patient died of respiratory failure on the 
26th postpartum day.
Autopsy findings consistent with cystic fibrosis were found 
in the lung, pancreas, and intestine.
Patient 2
DC, a 17-year-old white primigravid woman, was referred to 
Iowa Methodist Medical Center at 28 weeks' gestation for 
treatment of premature labor as well as progressive cough 
and shortness of breath. She had a 5-year history of produc­
tive cough and shortness of breath, but had not had a 
previous chest x-ray or hospitalization. A sister had died of 
pneumonia at age 9; cystic fibrosis had been suspected, but 
sweat chloride testing of the sister had been negative.
On admission, regular uterine contractions were noted, 
and the patient appeared chronically ill. Circumoral and 
conjunctival cyanosis were present. Diffuse rales and coarse 
breath sounds throughout both lung fields were noted, as
was a decreased expiratory rate. The cardiac examination was 
normal. The estimated fetal weight was 1000 g. The cervix 
was 3 cm dilated and 100% effaced.
Laboratory studies included hematocrit, 34.2%, and white 
blood cell count, 10,000/mm3. Arterial blood gases on room 
air showed Po2, 50 torr; Pcc>2, 29 torr; and pH, 7.46. These 
improved on 70% oxygen to Po2, 83 torr; Pco2, 26 torr; and 
pH, 7.50. Chest x-ray showed diffuse involvement with fluffy 
interstitial infiltrate predominantly in the upper lobes. Spu­
tum cultures subsequently grew Staphylococcus aureus. The 
impression was of premature labor with probable cystic 
fibrosis and superimposed pneumonia.
The patient was treated with intravenous hydration and 
isoxsuprine, which promptly stopped the contractions. She 
was also given betamethasone 12 mg orally for 2 doses at 24- 
hour intervals. The pneumonia was treated initially with 
intravenous cephalothin and aminophyllin plus 70% oxygen 
and chest physical therapy. A sweat chloride test done by 
quantitative pilocarpine iontophoresis revealed a chloride of 
70 mEq/liter (volume not specified). On the sixth hospital day 
contractions resumed and continued despite attempted tocol- 
ysis. Spontaneous rupture of the membranes occurred, and 
labor progressed rapidly to the spontaneous vertex delivery 
of a 1070-g female infant with Apgar scores of 8 and 9 at 1 and 
5 minutes, respectively. The infant was 29 weeks by gesta­
tional age assessment, and examination was otherwise unre­
markable. The infant, who did not have respiratory distress, 
had an uncomplicated course and was discharged in good 
condition. A sweat chloride study performed on the infant at 
1 month of age was within the normal range. A subsequent 
study at 33 months of age on the child revealed a sweat 
chloride content of 16 mEq/liter.
Post partum there was gradual improvement in the pa­
tient's pulmonary status. Repeat sweat chloride studies on 
the fifth postpartum day showed a chloride of 63 mEq/liter. 
Sputum cultures revealed no pathogenic organisms. She was 
discharged on the ninth postpartum day on a regimen of oral 
contraceptives, night oxygen supplementation, and dicloxa- 
cillin sodium for 2 weeks. She has done well for more than 40 
months post partum with only mild exacerbations of lung 
disease and return of blood gases to the normal range.
Discussion
Cystic fibrosis is the most com m on lethal genetic 
disease in white people, w ith a gene frequency esti­
mated as high as 1:20 and an  occurrence that may 
approach 1 in 1600 live births. The cause is unknow n, 
but appears to be related to an abnormality of exocrine 
gland secretions. Pathophysiologic features include 
immotile cilia, excessively thick mucus, pancreatic en­
zyme deficiency, and elevated sodium  and chloride in 
sweat. Pulm onary disease is the m ost serious clinical 
problem, and respiratory failure is the usual cause of 
death, although cirrhosis from progressive hepatic 
disease accounts for a small num ber of deaths in 
adolescents and adults.
A lthough the num ber of adults w ith cystic fibrosis
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increases each year, m ost diagnoses have been in 
children. However, an estim ated 2 to 3% of this group 
is not initially diagnosed until late adolescence or early 
adulthood. A lthough female fertility may be impaired, 
an increasing num ber of pregnancies in wom en with 
cystic fibrosis has been n o ted .611 The authors' experi­
ence suggests that there are wom en in whom  cystic 
fibrosis is not suspected or diagnosed until pregnancy.
Diagnosis
The presentation of cystic fibrosis in the older adoles­
cent or young adult differs from that in the infant or 
child, so the diagnosis is often not considered. The 
older patient may appear healthy and well nourished, 
instead of chronically ill and emaciated. Pancreatic 
function is usually deficient, but is often not sym ptom ­
atic. Recurrent unexplained respiratory sym ptoms 
such as chronic cough and sputum  production, al­
though sometimes mild, m ay be the only abnormality 
and should arouse suspicion. O ther pulm onary sym p­
toms and signs include hemoptysis, pneum othorax, 
bronchiectasis, and cor pulmonale. Initial diagnostic 
studies should include proper sweat chloride determ i­
nations and a chest x-ray. A positive family history is 
helpful, but is not always present.
The interpretation of sweat chloride testing has been 
said to be difficult in adults, because normal values 
up to 60 mEq/liter occur. 12 However, most authori­
ties believe that the test is a good discriminator in 
adults . 13'14
To obtain accurate and reproducible results, it is 
im portant that quantitative pilocarpine iontophoresis 
be done by an experienced technician. Because of the 
implications of either a false-positive or a false-nega­
tive diagnosis, patients should be referred to a center 
at which the test is perform ed frequently. The am ount 
of sweat m ust be quantitated, and the test should 
always be done in duplicate. The currently accepted 
technique for this procedure has been described by 
Gibson and Cooke . 15 M any laboratories currently use 
"quick" m ethods (the Orion test and Med therm test), 
which do not involve quantitation of sweat. These 
methods result in both false-positive and false-nega­
tive results, as most recently docum ented by Denning 
et al, 16 and should not be used. It m ust be em phasized 
that the diagnosis of cystic fibrosis is not made on the 
basis of sweat chloride testing alone. It is essential to 
consider the patient's entire clinical picture in the 
diagnostic process.
A few rare disorders are known to raise chloride 
values: hyperhydrotic ectodermal dysplasia, untreated 
adrenal insufficiency, and renal diabetes insipidus. 
None of these should present diagnostic difficulty. The 
effect of pregnancy on sweat chloride values is not
known. It is interesting that all 4 patients diagnosed 
during pregnancy had chloride values less than 100, 
and 2 were in the borderline range. Some information 
is available about the effects of horm ones on sweat 
chlorides. Chloride values in adult wom en are the 
same as in adult m en and  have not been found to vary 
with the m enstrual cycle. In adults, adm inistration of 
glucocorticoids and mineralocorticoids has not been 
found to alter sweat chloride values. Cervical mucus 
composition is altered in girls w ith cystic fibrosis. 17
Pulm onary function tests are usually abnormal and 
reflect a primarily obstructive process affecting the 
small airways. FEV, and  maximum midexpiratory flow 
rates are decreased. The prognosis is related to the 
severity of the obstructive abnorm ality . 18 There may 
also be a restrictive com ponent to the pulmonary 
function abnormality.
The chest x-ray is usually abnormal. The upper lobes 
are usually involved and show varying degrees of 
fibrosis, cystic change, atelectasis, and mucus plug­
ging. Prom inent interstitial m arkings are common. 
Hyperinflation is less common in adults than in chil­
dren. Acute infiltrates represent superim posed pneu­
monitis. 1319 A lthough the findings are not pathogno­
monic, patchy diffuse upper lobe changes, irregular 
aeration, or air trapping in a young patient with a 
history of respiratory sym ptoms is highly suggestive.
Arterial blood gases are usually abnormal. Typical 
initial changes are hypoxia with a norm al C 0 2. Hyper- 
carbia is seen in m ore advanced cases.
Pancreatic insufficiency may be present. It is proba­
bly not necessary to test the duodenal secretions for 
pancreatic enzymes, although this was done routinely 
in the past. Fecal fat determ ination can be used to 
determine the need for pancreatic enzyme replace­
ment, but clinical evaluation is usually satisfactory. 
O ther evidence of gastrointestinal tract dysfunction 
includes cirrhosis, portal hypertension, carbohydrate 
intolerance, volvulus, obstruction, or intussusception.
Salt depletion m ay be seen (and may also occur in 
breast-fed infants of m others w ith cystic fibrosis). 
O ther abnormalities that may be encountered include 
an increased susceptibility to heat stroke, skeletal 
demineralization, and  nasal polyposis.
Management
Once the diagnosis of cystic fibrosis is established, 
m anagem ent m ust be aggressive. Since Larsen's6 dis­
cussion in 1972, new  information about this disease in 
adults has become available. 13,14 Based on these new 
facts as well as the reported cases, the authors would 
like to present w hat seems to be a logical approach. For 
all these wom en, pregnancy should be considered
4S Johnson et al Cystic Fibrosis in Pregnancy Obstetrics & Gynecology
high risk, and the regional specialists most familiar 
with cystic fibrosis should be consulted.
A careful history should be taken, em phasizing 
pulmonary and gastrointestinal symptoms. Exercise 
tolerance should be estimated. Studies should include 
a chest x-ray, pulm onary function studies, arterial 
blood gases, and sputum  culture to evaluate the respi­
ratory function. The patient should be evaluated for 
malabsorption. Liver function studies and a glucose 
tolerance test complete the evaluation of the gastroin­
testinal system. Additional studies should include se­
rum electrolytes, hemoglobin and hematocrit, urinaly­
sis, and in appropriate patients an electrocardiogram 
and echocardiogram to assess right ventricular func­
tion.
A functional classification with prognostic value was 
developed in 1972 and should be done at one of the 
initial visits. 18 Although this may not predict pregnan­
cy outcome, it can be helpful in counseling the patient 
about her future.
Follow-up visits should occur at least every 2 weeks 
until approximately 26 weeks' gestation and weekly 
thereafter. Pulmonary function studies, arterial blood 
gases, sputum  culture, weight, and blood count 
should be assessed m onthly and systems should be 
carefully reviewed. Ultrasound may be useful for dat­
ing purposes as well as assessm ent of the fetus for 
appropriate growth. Fetal heart rate testing should be 
done in the third trimester.
Pulmonary M anagem ent
The major therapeutic goal is maintenance of open 
airways and control of pulm onary infection. The for­
mer is achieved by adequate hydration and chest 
physiotherapy that includes percussion and postural 
drainage 3 to 4 times daily. There is increasing clinical 
evidence that a vigorous aerobic exercise program  is 
important for bronchial toilet. Prolonged bed rest 
should be avoided, and the patient's ability to tolerate 
exercise should be considered in both prenatal and 
early pregnancy counseling.
Pulmonary infection should be suspected if pulm o­
nary function studies deteriorate. Proper collection of 
sputum specimens is essential. Cultures accurately 
representing the lower respiratory tract can be ob­
tained by having the patient rinse her m outh with 
saline before coughing, and then transporting the 
sputum to the laboratory within 20 m inutes for plating. 
The most common organisms are P aeruginosa, Hemo­
philus influenzae, and S aureus.
P aeruginosa is the m ost common respiratory patho­
gen in cystic fibrosis. Substantial investigational effort 
has been directed toward the frequent association of 
maternal cystic fibrosis and pulm onary colonization
and/or infection w ith this organism. diSant' Agnese 
and Davis, 13 in a major review article of cystic fibrosis 
in adults, note that 90% of such patients have had 
chronic obstructive bronchitis associated with P aeru­
ginosa. The majority of Pseudomonas isolates recov­
ered from patients with cystic fibrosis produce an 
unusual and relatively specific polysaccharide slime­
like material. This material has been characterized as a 
polymer of uronic acid20 and is widely thought to 
enhance the persistence of pseudom onads in such 
patients .21-22 These mucoid strains of pseudom onads 
are seldom seen except in cystic fibrosis. Some authors 
recommend the diagnosis of cystic fibrosis be seriously 
considered w henever such organisms are isolated from 
patients w ith bronchitis.23 Most patients with cystic 
fibrosis are initially colonized w ith nonm ucoid Pseudo­
monas strains that subsequently evolve into mucoid 
forms of the same strain .24 After such a transforma­
tion, the organism is very seldom eradicated and is 
usually associated w ith progressive deterioration in 
the patient's condition .25 There is evidence to suggest 
that the increased virulence is the result of impaired 
phagocyte clearance and decreased effectiveness of 
opsonic antibodies.26,27 Similar mucoid strains of Esch­
erichia coli have also been recently identified in the 
respiratory tracts of patients with cystic fibrosis.28
Treatm ent with an appropriate antibiotic should 
continue for at least 2 weeks, and  some patients may 
need continuous antibiotic therapy. Organism-specific 
therapy is critical. Staphylococcus should be treated 
with a penicillinase-resistant penicillin or cephalospo­
rin. Ampicillin, amoxicillin, or intravenous carbenicil- 
lin can be used for H  influenzae. Pseudomonas is the 
most difficult to eradicate.
Parenteral therapy is m andatory for Pseudomonas 
pneum onia. In patients w ith norm al renal function, 
divided doses of gentam icin or tobramycin totally 5 
mg/kg/day inhibit m ost strains of Pseudomonas. How­
ever, amikacin in doses of 15 mg/kg/day is also effec­
tive and m ay be particularly useful against strains that 
have developed resistance to gentamicin or tobramy­
cin. Ticarcillin (16 to 20 g/day) and carbenicillin (24 to 
30 g/day) are also frequently effective. Enhanced anti- 
Pseudomonas activity can be achieved by combination 
therapy w ith an aminoglycoside and either ticarcillin 
or carbenicillin.
Pulmonary function tests can be used to monitor 
clinical progress. Fortunately, all these antibiotics can 
be used with relative safety in pregnancy. Although 
tetracycline is commonly used in the nonpregnant 
patient, it should not be used during pregnancy.
If the patient is hypoxic, supplem ental oxygen is 
necessary. Theophylline or adrenergic bronchodilator 
agents are often used, as bronchospasm  is frequently 
present. Interm ittent positive-pressure breathing, al­
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though recom m ended in the past, is now believed 
ineffective except to deliver medication. The risk of 
pneumothorax is a contraindication to its use . 12 Because 
the major cause of deterioration and eventual death is 
related to pulm onary dysfunction and infection, it is 
especially im portant that the patient be im pressed at 
the start w ith the im portance of meticulous pulm onary 
care, including aerobic exercise.
Patients who complain of increased shortness of 
breath or sputum  production or in w hom  respiratory 
function deteriorates usually have infection, but the 
possibility of spontaneous pneum othorax or the devel­
opm ent of cor pulmonale should be considered. H e­
moptysis secondary to bronchiectasis is common and 
should be treated with antibiotics. Rarely, massive or 
life-threatening hem optysis unresponsive to antibiot­
ics requires surgical therapy.
The prognosis for a patient with cor pulm onale as a 
result of long-standing hypoxia and respiratory insuffi­
ciency is poor. Every patient should be screened w ith 
arterial blood gas determ ination, electrocardiogram, 
and spirometry. If the results of these studies point to 
cor pulmonale, diagnostic echocardiography should be 
considered for corroborative evidence,29,30 because the 
disease is a potentially serious problem  in pregnancy.
Pancreatic Insufficiency
If there is evidence of pancreatic insufficiency, pancre­
atic extracts should be considered. Even though the 
patient may not have m arked malabsorption, these 
supplem ents are believed to decrease the risks of 
cholelithiasis and may facilitate nutrition during preg­
nancy. A low-fat diet is helpful. Also, adult patients 
with pancreatic insufficiency are at increased risk for 
meconium ileus equivalent, and there may be value in 
pancreatic extract to prevent this complication.
Meconium ileus equivalent is characterized by the 
triad of interm ittent recurrent right lower quadrant 
pain, right lower quadrant mass, and  radiographic 
evidence of mechanical obstruction .31 The pathogene­
sis of this problem is thick stool in the ascending colon 
and terminal ileum. Complications include complete 
obstruction, intussusception, and volvulus. The pa­
tient may have acute abdom inal pain, and this diagno­
sis needs to be considered along with appendicitis and 
adnexal problems. The diagnosis can only be m ade 
radiographically, and the treatm ent consists of meglu- 
camine diatrizoate (Gastrografin) enemas. Surgery is 
only rarely required.
Glucose intolerance is common am ong adult pa­
tients; it may occur in more than 50%. Insulin is only 
occasionally required, so dietary m anagem ent should 
suffice for the pregnant patient.
O ther gastrointestinal complications include biliary
cirrhosis and focal hepatic lesions that may cause 
elevation of liver function studies. Portal hypertension 
can occur. Acute pancreatitis is not uncom m on and 
should be m anaged conservatively with intravenous 
fluids and nasogastric intubation; the benefit of cimeti- 
dine is unproved, despite its use in the first patient 
reported here.
The patient with cystic fibrosis w ho has abdominal 
pain should be evaluated for pancreatitis, meconium 
ileus equivalent w ith either obstruction or intussuscep­
tion, and cholecystitis in addition to the usual causes of 
abdominal pain in the  pregnant woman.
Labor and Delivery
There appears to be a higher incidence of premature 
labor in wom en w ith cystic fibrosis.6,11 The use of 
tocolytic agents does not appear to be contraindicated 
for pulm onary reasons unless severe cor pulmonale is 
present, although the w isdom  of suppressing labor 
w hen hypoxia may be the cause requires careful con­
sideration. The use of steroids to induce fetal pulmo­
nary m aturation is controversial under any circum­
stance. W hen m aternal infection is present, steroid 
induction of labor should be undertaken with caution, 
although the short regim ens used may not present a 
problem. The m anagem ent of labor and delivery is 
similar to that used with high-risk wom en with cardiac j 
and pulm onary problems. Respiratory depressants 
should be avoided. Adequate hydration is essential.
The second stage m ay be shortened w ith outlet for­
ceps. Epidural anesthesia w ould be preferable to gen­
eral anesthesia for either labor or delivery. Cesarean 
section should be done only for obstetric reasons.
Based on the reported cases, m aternal pulmonary 
decom pensation can take place in the puerperium  (up 
to several months), and the patient should be moni­
tored closely during this time.
Prognosis
Until recently, the m aternal m ortality in reported cases 
was h igh .6 A survy of 119 cystic fibrosis centers report­
ed by Cohen et a l"  adds perspective. O ne hundred 
twenty-nine pregnancies were identified; of the 97 
completed pregnancies, 86 infants were viable. There 
were no maternal deaths during pregnancy; however,
15 of 84 wom en died w ithin the first 6 m onths post 
partum . This rate w as similar to the expected mortality 
of nonpregnant patients. The rates of stillbirth (6.2%)/ 
neonatal death (5.2%), and prem aturity (16.5%) were 
higher than  the control data. O ne infant had cystic 
fibrosis (1.2%).
Although this report is encouraging in that the 
majority of pregnancies resulted in a living infant and
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mother, the incidence of pregnancy wastage was high. 
Also, many of the wom en who died had exacerbation 
of infection during pregnancy. This was also true of 
the present authors' first patient.
The literature suggests that maternal mortality is 
related to prepregnancy pulm onary status, and it has 
been suggested that a vital capacity of less than 1 liter 
places the m other at serious risk. O ther ominous signs 
are extensive em physem a, atelectasis or bronchiecta­
sis, significant cor pum onale, progressive pulm onary 
hypertension, progressive hypoxia, pulm onary hem ­
orrhage, and pneum othorax. Pregnancy termination 
should be considered w hen any of these is p resent.6,11
Summary
It is probable that an increasing num ber of wom en 
with an established diagnosis of cystic fibrosis will 
become pregnant. In addition, pregnant wom en w ith 
unexplained recurrent respiratory sym ptoms, includ­
ing infections, hem optysis, and asthma-like sym p­
toms, deserve evaluation for this disease. If the chest 
x-ray is abnormal, sweat chloride testing should be 
considered, even if the prepregnancy history is not 
suggestive of cystic fibrosis. Certainly any patient w ith 
a family history of cystic fibrosis should be tested. 
Patients with significant pulm onary compromise or 
complications should be counseled regarding the risks 
and offered the option of abortion and/or sterilization.
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